What if prescription costs were tied to outcomes and how patients do on their prescriptions? It's already happening. Eric Elliott, president of CignaPharmacy Management, tells the Chicago Tribune's Bruce Japsen about new ways health benefits companies are working to provide more effective treatments.
Putting a Price on Quality When it Comes to Prescriptions

Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
What if prescription costs were tied to outcomes and how patients do on their prescriptions? It's already happening. Eric Elliott, president of CignaPharmacy Management, tells the Chicago Tribune's Bruce Japsen about new ways health benefits companies are working to provide more effective treatments.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Implementing a Multidisciplinary Approach to Heart Failure: Patient Identification and Treatment Using Novel Device Therapy
Evolutions in Duchenne Muscular Dystrophy: Treatment Implications for the Present and Future
IgG4-RD Case Conversations: Systemic Disease Infiltrating the Skull Base
Episode 2 Part B: Effectively Transferring Over the CKD Patient at the Right Time
HF Management for Patients with Comorbid Conditions
Level Up Your Skills: Tailoring Management of HF
Analysis of Patients With and Without AF Living With HFmrEF/HFpEF: FINEARTS-HF
Mode of Death in Patients With HFmrEF/HFpEF: The FINEARTS-HF Trial
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?